Our data revealed that the plasma FGL-1 level was significantly higher in the IPN group compared with the No-IPN group ((34.17 ± 15.19) ng/mL vs. (17.40 ± 14.80) ng/mL, p = 0.011) (Figure 3a). Here, FGL1 is linked to bile duct papillary neoplasm.